Search

'Losing direction': Allergan investors are unhappy after a wild 4 hour takeover drama

'LOSING DIRECTION': ALLERGAN INVESTORS ARE UNHAPPY AFTER A WILD 4 HOUR TAKEOVER DRAMA

Allergan's stock closed down 4% on Thursday, after the pharma giant said it was "in the early stages of considering a possible offer"...

A bidding war is brewing over $50 billion drugmaker Shire

A BIDDING WAR IS BREWING OVER $50 BILLION DRUGMAKER SHIRE

Shire rejected Takeda's $60 billion takeover bid on Thursday, and now Allergan's reportedly entering the bidding war. The $60 billion...

 
 
 
Bio Roundup: Biotech IPOs, Migraine Progress, Takeda Woos Shire & More

BIO ROUNDUP: BIOTECH IPOS, MIGRAINE PROGRESS, TAKEDA WOOS SHIRE & MORE

If the recent IPO activity seems to be on overdrive, it's not your imagination. The number of companies filing to go public in the...

Out With the Old and in With the NEW!

OUT WITH THE OLD AND IN WITH THE NEW!

Here at Spring Ridge Plastic Surgery, we are excited about the new generation of Gummy Bear breast implants by Natrelle®. Allergan,...

 
 
 

ALLERGAN TO PRESENT AT THE 36TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

DUBLIN, Dec. 26, 2017 /PRNewswire/ - Allergan plc , a leading global biopharmaceutical company, today announced that Chairman and CEO...

 
 
 
Xconomy Newcomer Award Winner Amy Schulman on Boston Biotech Life

XCONOMY NEWCOMER AWARD WINNER AMY SCHULMAN ON BOSTON BIOTECH LIFE

Amy Schulman is relatively new not just to Boston, but also to biotech. Before she moved to Boston in 2014 to join Polaris Partners,...

Botox maker Allergan raises the lower end of its earnings forecast

BOTOX MAKER ALLERGAN RAISES THE LOWER END OF ITS EARNINGS FORECAST

Reuters/ Jim Young Allergan missed on revenue, but beat on earnings. The company raised the lower end of its adjusted earnings guidance....

 
 
 
 
 
 
Botox Cosmetic Approved for Forehead Lines

BOTOX COSMETIC APPROVED FOR FOREHEAD LINES

The U.S. Food and Drug Administration has granted Allergan's Botox Cosmetic approval for its third indication, the temporary improvement...

The maker of Botox has turned to the oldest trick in the book to save its cratering stock

THE MAKER OF BOTOX HAS TURNED TO THE OLDEST TRICK IN THE BOOK TO SAVE ITS CRATERING STOCK

To combat recent stock weakness, Botox-maker Allergan is resorting to the oldest trick in the book: share buybacks . On Monday, it...

 
 
 
Seeking to Cash in For Investors Again, Rhythm Pharma Files For IPO

SEEKING TO CASH IN FOR INVESTORS AGAIN, RHYTHM PHARMA FILES FOR IPO

Most biotechs pursue either a sale or an IPO to reward their investors. Rhythm Pharmaceuticals is now trying to accomplish both. A...

 
 
 
Advances in Breast Implant Technology

ADVANCES IN BREAST IMPLANT TECHNOLOGY

Breast Implant technology has improved immensely over the past few years. Recently, Allergan's Natrelle® implants have been FDA approved...

 
 
 
Eli Lilly Migraine Drug Hits Study Goals, Paves Way for FDA Filing

ELI LILLY MIGRAINE DRUG HITS STUDY GOALS, PAVES WAY FOR FDA FILING

An Eli Lilly drug developed to stop migraine headaches before they can start hits its main goals in a late-stage clinical trial, the...

Pieris Adds Another Partner, Gets $45M in AstraZeneca Lung Drug Deal

PIERIS ADDS ANOTHER PARTNER, GETS $45M IN ASTRAZENECA LUNG DRUG DEAL

A protein drug developer with roots in Germany continues to grow in Boston, MA, with the help of another partnership. Pieris Pharmaceuticals...

 
 
 
There May Be a New Use for Botox, and We Can Bet You've Never Heard This One Before

THERE MAY BE A NEW USE FOR BOTOX, AND WE CAN BET YOU'VE NEVER HEARD THIS ONE BEFORE

New day, new use for Botox Cosmetic . And this time, a lesser-known oral condition is getting in on the game. You May Also Like: Allergan...

Allergan in Final Push to Have Botox Approved to Treat Depression

ALLERGAN IN FINAL PUSH TO HAVE BOTOX APPROVED TO TREAT DEPRESSION

We already know that Botox Cosmetic can treat more than just lines and wrinkles-the Food and Drug Administration has approved the neurotoxin for...